Skip to content

Exploratory Research on the Efficacy Evaluation of Electroacupuncture in the Treatment of Cerebral Apoplexy and Paralysis Stage Based on the Theory of "Treating Flaccid Paralysis by Yangming A

Exploratory Research on the Efficacy Evaluation of Electroacupuncture in the Treatment of Cerebral Apoplexy and Paralysis Stage Based on the Theory of "Treating Flaccid Paralysis by Yangming A

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005445
Enrollment
Unknown
Registered
2021-12-26
Start date
2021-12-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sponsors

Huashan Hospital,Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.For the patients who met the diagnostic criteria for ischemic stroke (with reference to the 2019 edition of Chinese diagnostic criteria for cerebrovascular diseases) and were confirmed as ischemic stroke by CT or MRI, the lesion suggested that the type was hemiplegia due to unilateral hemispheric injury; 2.The patient suffers from the first stroke, and the condition is basically stable with no conscious disorder; 3.Upper limb Brunnstrom grade 1; Ashworth upper extremity score: 0; 4.Vital signs are stable; 5.Aged between 45-75 years old; No gender limitation; 6.The patient or his/her immediate family members and spouse sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.There are diseases or conditions that seriously affect patients' activities, such as important organ failure or critical condition, and cancer; 2.Patients combined with systemic infection, or the condition is seriously unstable; 3.Patients complicated with severe musculoskeletal diseases; 4.Patients complicated with severe cognitive and mental diseases; 5.Fear of acupuncture and dizziness; 6.Patients with heart disease; 7.The affected upper limb of the patient has metal implants, and the patient is allergic to EEG ointment; 8.Pregnant and lactating women; 9.Patients have participated in other clinical trials that affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
FuAssessment-upper Limb;

Secondary

MeasureTime frame
Barthel Index;Brunnstrom staging;manual muscle test(MMT);Hand laser speckle blood flow imaging;NIH Stroke Scale, NIHSS;EEG;Modified Ashworth Scale;

Countries

China

Contacts

Public ContactJie Jia
shannonjj@126.com13611722357

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026